INFLAMMATORY-IMMUNE AND METABOLIC PREDICTORS OF STRUCTURAL AND FUNCTIONAL CHANGES IN THE MYOCARDIUM AND DAILY PRESSURE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS

Authors

  • Shavkatova Mutabar Nodirovna Author
  • Rakhimova Madina Bokhodirovna Author

Abstract

Cardiovascular diseases continue to occupy leading positions in the structure of general mortality and disability of the population, while arterial hypertension is considered one of the main modifiable risk factors for the development of adverse cardiovascular outcomes [5, 15]. Modern understanding of the pathogenesis of arterial hypertension extends beyond isolated hemodynamic disorders and increasingly emphasizes the role of systemic inflammation, immune dysfunction, and metabolic disorders in the formation of target organ damage, including the heart [2].

References

1. Arutyunov, G. P. Daily monitoring of blood pressure in clinical practice / G. P. Arutyunov, V. Yu. - 2018. - Vol. 58, No. 3. - P. 72-80

2. Arterial hypertension and myocardial remodeling: modern approaches to risk assessment / V. Yu. - 2016. - Vol. 56, No. 10. - P. 5-14

3. Nasonov, E. L. Rheumatoid arthritis as a factor of high cardiovascular risk / E. L. Nasonov // Scientific and Practical Rheumatology. - 2015. - Vol. 53, No. 1. - P. 5-12

4. Popkova, T. V. Cardiovascular complications in rheumatoid arthritis: pathogenetic aspects / T. V. Popkova, E. L. Nasonov // Therapeutic Archive. - 2016. - Vol. 88, No 5. - P. 76-83.

5. Chazov, E. I. Cardiovascular Diseases: Contemporary Problems and Solutions / E. I. Chazov // Therapeutic Archive. - 2020. - Vol. 92, No. 9. - P. 4-10.

6. Abdurahimov, A. G., Khalmetova, F. I. (2023). Non-steroidal anti-inflammatory drugs in patients with deforming osteoarthritis and arterial hypertension: analysis of the effects of целекоксиб and мелоксикам on antihypertensive agents. Treatment optimization. Atherosclerosis, 19 (3), 186-187

7. Avina-Zubieta, J. A. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis / J. A. Avina-Zubieta, H. Thomas, V. Sadatsafavi [et al.] // Arthritis Care & Research. - 2012. - Vol. 64, No. 4. - P. 573-583.

8. Rakhimova, M. B., Akhmedov, K. S., & Turayev, Y. A. (2021). Endothelial dysfunction as a link in the pathogenesis of ankylosing spondylitis against the background of a new coronavirus infection. Academics: An International Multidisciplinary Research Journal, 11 (3), 2493-2498.

9. Axmedov, I. A., Xalmetova, F. I., and Zaripov, S. I. (2024). The role of heart rhythm disorders in the early detection of cardiovascular system disorders in patients with rheumatoid arthritis.

10. Lang, R. M. Recommendations for echocardiography of the heart chambers in adults / R. M. Lang, L. P. Badano, V. Mor-Avi [et al.] // European Heart Journal - Cardiovascular Imaging. - 2015. - Vol. 16, No. 3. - P. 233-270.

11. Nurmohamed, M. T. Cardiovascular risk in rheumatoid arthritis: when does it begin and how to manage it? / M. T. Nurmohamed // Annals of the Rheumatic Diseases. - 2015. - Vol. 74, No. 6. - P. 997-999.

12. Shovkatova, M. N., & Rakhimova, M. B. (2025). ARTIFICIAL INTELLIGENCE IN DIGITAL STRATIFICATION AND DYNAMIC CONTROL OF CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION AND RHEUMATOID ARTHRITIS. FARS, International Journal of Education, Social Science & Humanities, 13 (12), 7-14.

13. Rakhimova, M. B., Akhmedov, K. S., & Turayev, Y. A. (2021). Endothelial dysfunction as a link in the pathogenesis of ankylosing spondylitis against the background of a new coronavirus infection. Academics: An International Multidisciplinary Research Journal, 11 (3), 2493-2498.

14. Ridker, P. M. C-reactive protein and the prediction of cardiovascular events / P. M. Ridker // Circulation. - 2003. - Vol. 107, No. - P. 363-369.

15. Khalmetova, F. I., Akhmedov, K. S., Buranova, S. N., Rakhimova, M. B., Rakhimov, S. S., & Abdurahimova, L. A. (2023). Immunological features of reactive arthritis of various etiologies. Journal of Coastal Life Medicine, 11, 1322-1325

Downloads

Published

2026-03-27